Luis Fabián
Lorenzo Díaz

Fabián Lorenzo Díaz studied Biology (1996-2001) at the University of La Laguna (ULL). In 2009 defended his doctoral thesis at the Complutense University of Madrid, working on molecular mechanisms of horizontal gene transfer. He has worked in different international research groups: Instituto de Biología Molecular de Rosario (Argentina, 2006); Johns Hopkins University (Baltimore-USA, 2007); and Institute ZIK-Septomics (Germany, 2015). Since 2016, he is an assistant professor in the area of Genetics of the ULL, as well as academic deputy director of the Master in Biomedicine and scientific head of the Genomics Service at the ULL (SEGAI). In this period, he has gained experience in next-generation sequencing technologies (bacterial genomes, human exomes, transcriptome, and microbiome). Currently, he is involved in research projects aiming to analyze the role of the human microbiome and genetic variation in developing asthma and/or exacerbation processes in asthmatic patients. General indicators of quality of scientific production (from 2010 to 20): Number of articles: 28 Number of theses supervised: 1 (2 additional ongoing) Participation in research projects: 16 Participation in research projects (from 2016): A) As Principal investigator: 1. Búsqueda de marcadores genéticos relacionados con las exacerbaciones del asma: estudio de asociación genómico y análisis del microbioma respiratorio. SAF2017-83417-R. Ministerio de Ciencia, Innovación y Universidades. 2018-2021. Co-PI with María Pino-Yanes. 2. Automatización y ampliación de procesos en el Servicio de Genómica SEGAI. EQC2019-005677-P. Ministerio de Ciencia, Innovación y Universidades. 2020-21. B) As member of the research team: 3. Evaluación de los endotipos del asma: aproximación clínica, inmunológica y genética. Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC). 2020-2021. IP: Ruperto González and Paloma Pozas. 4. Nuevas herramientas para viejas preguntas: Estudio del poblamiento aborigen canario usando tecnologías genómicas de última generación. Fundación CajaCanarias. 2018-2020. PI: Rosa Fregel Lorenzo 5. SysPharmPediA: Systems pharmacology approach to difficult-to-treat pediatric asthma. ERA-Net ERACoSysMed 99 (Horizon 2020). 2016-2019. PI: Anke-Hilse Maitland van der Zee. 6. Systems pharmacology approach to difficult-to-treat pediatric asthma. AC1500015. Instituto de Salud Carlos III. 2016-2018. PI: María Pino-Yanes.